Nagamine Takahiko
Psychiatric Internal Medicine, Sunlight Brain Research Center, Hofu 7470066, Yamaguchi, Japan.
World J Clin Cases. 2025 Jun 6;13(16):103372. doi: 10.12998/wjcc.v13.i16.103372.
The present paper addresses two issues pertaining to the use of virtual reality (VR). One issue pertains to the equipment utilized. VR technology can be classified into two main categories: Immersive and non-immersive. The immersive type of technology necessitates the use of substantial equipment, yet it is demonstrably efficacious. Furthermore, the efficacy of this approach is enhanced when combined with relaxation and biofeedback techniques. The other issue is that the efficacy of this approach is diminished when applied to chronic pain, in comparison to acute pain. The relief of chronic pain is a challenging endeavor due to the diminished functionality of the medial prefrontal cortex (mPFC) within the default mode network. Given the close relationship between the mPFC and the reward system dopamine, it is essential to develop a program that activates the reward system dopamine through the use of VR technology.
本文探讨了与虚拟现实(VR)使用相关的两个问题。一个问题与所使用的设备有关。VR技术可主要分为两类:沉浸式和非沉浸式。沉浸式技术需要使用大量设备,但其效果显著。此外,当与放松和生物反馈技术结合使用时,这种方法的效果会增强。另一个问题是,与急性疼痛相比,这种方法应用于慢性疼痛时效果会减弱。由于默认模式网络中内侧前额叶皮质(mPFC)功能减退,缓解慢性疼痛是一项具有挑战性的工作。鉴于mPFC与奖励系统多巴胺之间的密切关系,开发一个通过使用VR技术激活奖励系统多巴胺的程序至关重要。